UCB UCLPartners Doctoral Training Programme

The objective of this programme is to provide an innovative approach to basic and translational science, drug discovery and therapeutic strategies, incorporating cross institutional and industrial pharma based training. Students will benefit from a secondment in industry at UCB, in addition to training and transferable skills courses through UCL and QMUL. 

PhD applications are invited for the following three projects: 

1) Investigating the tumour extracellular matrix in the inhibition of anti-tumour immunity
Supervisors: Dr Oliver Pearce and Professor Fran Balkwill, Barts Cancer Institute, QMUL

2) Biomechanical cues direct cell reprogramming in tissue repair and scarring
Supervisor: Dr Markella Ponticos and Professor Justin Hsuan, UCL

3) Identification of mechanisms predisposing to renal fibrosis in chronic kidney disease
Supervisors: Professor Robert Kleta and Dr Jill Norman, UCL

Applicants should have a good honours degree (minimum 2(i) or equivalent) with a strong background in biomedical science.

The studentship is fully funded for three years and will commence on 2 October 2017. It includes tuition fees and the student will receive a minimum tax free stipend per annum of £20000, increasing by 3% every year. The studentship is open to all nationalities, however is subject to university admissions requirements for PhD study.

Informal queries may be made to Annabelle Scott a.n.scott@qmul.ac.uk. Please direct any project related questions to the relevant Supervisor (listed above). 

How to apply: Please send a covering letter and CV to a.n.scott@qmul.ac.uk indicating the project you would like to apply for. 

Deadline for applications: 1 July 2017. Interviews will be held in the middle of July 2017.